Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Research premium increased to 12 percent

Photo: Philipp von Lattorff, Boehringer Ingelheim Austria © Photo: Philipp von Lattorff, Boehringer Ingelheim Austria

One of the 2015/16 tax reform measures to strengthen companies operating in Austria is an increase in the research premium from ten to twelve percent starting in 2016. This step improves the good business environment which already exists in Austria for the benefit of corporate innovations, as confirmed by the German pharmaceutical company Boehringer Ingelheim, which is continually expanding its research activities in Austria. The conditions for the research and development of complex medicines, for example as required in the field of immune-oncology, are very good in Austria, Lattorff said in an interview with the daily newspaper “Der Standard”. The Boehringer Ingelheim group, which spends 200 million euros for clinical and non-clinical research annually, employs 1,400 people in Vienna, including 270 researchers from some 30 nations.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • 17. Mittelstandstag FrankfurtRheinMain

    07.11.2019, Frankfurt on the Main, Germany

  • MEDICA 2019

    18.11.- 21.11. 2019, Dusseldorf, Germany, Germany

Austria Map

Find the perfect location for your company

We are lucky to benefit from a lot of reserach incentives here in Austria. We are very proud to be here as Austria is an ideal location for research.

TachoEASY Austria

Logo
More testimonials

news from the business location Austria

Siemens: New robot welding plant in Graz

Siemens Mobility has put a new robot-controlled frame welding facility into operation in Graz.

Coming back for seconds: Why big brands expand their (R&D) presence in Austria

The high-tech multinational Infineon is investing more than EUR 1.6 billion to expand its main facility in Austria. The pharmaceutical company Octapharma is massively expanding its Vienna-based operations at a cost of EUR 142 million. Headlines like these have recently caused people to sit up and take notice. But the question is: why is Austria as a research location so popular with international firms which are already established here?

More news All blog posts